Arya Sciences Acquisition Iv (ARYD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ARYD Annual Balance Sheets →
From Arya Sciences Acquisition Iv through Mar 31 2023, shifts in Mar 31 2024's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2024)
(Dec 31 2023) (Sep 30 2023) (Jun 30 2023) (Mar 31 2023)
Assets
Cash & cash equivalent0.09
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.05
Total Current Assets0.14
Other Assets, Noncurrent37.00
Total Assets37.26
Liabilities
Accounts Payable, Current AC0.16
Accrued Liabilities, Current AC8.60
Convertible Notes Payable, Current NO3.15
Other Liabilities, Current0.24
Total Current Liabilities12.15
Total Long-term Debt0.00
Other liabilities, Noncurrent2.62
DeferredUnderwritingFeePayableNonCurrent2.62
Total Liabilities14.76
Stockholders' Equity
Additional Paid In Capital Common Stock0.52
Retained Earnings / Accumulated Deficit-15.04
Other Equity-37.02
Common Stockholder's Equity-51.54
Non-controlling interests & other37.02
Total Stockholder's Equity-14.52
Liabilities & Stockholder's Equity37.26
4 historic quarters locked

Sign in to unlock the full Arya Sciences Acquisition Iv balance sheet history.

About Arya Sciences Acquisition Corp Iv Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001140361-24-026910

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.